Press Releases Oct 19, 2020

Governor Laura Kelly Celebrates Economic Development, Innovation at Groundbreaking for Kansas University BTBC Expansion

Oct 15, 2020 Governor Laura Kelly today applauded the announcement of the Phase III expansion of the Bioscience & Technology Business Center (BTBC) at the University of Kansas, and introduction of the new KU Innovation Park. The Phase III expansion includes a new 70,000-square-foot facility, which will feature fully functional wet labs, offices, and collaborative […]

Press Releases Sep 29, 2020

Kansas-Based Company ViroVax Licenses Adjuvant to be Used in India’s First COVID-19 Vaccine in Human Trials

Kansas-based ViroVax LLC has licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International Limited, an Indian biotech company. Bharat Biotech is partnering with the Indian Council of Medical Research (ICMR) to produce India’s first COVID-19 vaccine approved for human trials, COVAXIN®, which uses ViroVax’s adjuvant technology. COVAXIN® is an inactivated vaccine derived from a strain of […]

Press Releases Sep 08, 2020

Doosan Bobcat North America Partners with Ainstein AI, Inc.

WEST FARGO, N.D. (June 9, 2020) Doosan Bobcat North America announced today it has partnered with Ainstein AI, Inc. – a radar technologies company headquartered in Lawrence, Kansas – to develop next-generation radar sensor systems for Bobcat® equipment. Through this partnership, Ainstein and Doosan Bobcat North America will collaborate to create radar-based sensing solutions to […]

Press Releases Aug 06, 2020

Merck Animal Health Completes Acquisition of IdentiGEN

AUGUST 05, 2020 Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture MADISON, N.J.–(BUSINESS WIRE)– Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of IdentiGEN, a leader in DNA-based […]

Press Releases Jul 21, 2020

Clara Biotech Receives Grant to Fund Eleven New Jobs

FOR IMMEDIATE RELEASE Contact: James West, CEO Direct: 913.356.9682 jim@clarabio.tech LAWRENCE, Kan. (July 1, 2020) — Local startup, Clara Biotech Inc., was awarded $50,000 in grant funding from the Kansas Department of Commerce’s Job Creation Fund to support the creation of eleven new highly-skilled Kansas jobs over the next three years. The funding will assist […]

Press Releases Jun 29, 2020

BioKansas Awarded Grant from Burroughs Wellcome Fund to Develop Novel Kansas-Based Training Program

BioKansas has received a grant from Burroughs Wellcome Fund to develop a bioscience industry immersion program for PhD students. The new program aims to broaden area students’ understanding of career options, expand their professional networks, provide awareness of area job opportunities, and preparation for career advancement. June 26, 2020 11:38 AM Eastern Daylight Time SHAWNEE, […]

Press Releases Jun 02, 2020

LIGAND CEO ISSUES LETTER TO CAPTISOL CUSTOMERS

June 01, 2020 SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Chief Executive Officer John Higgins issued a letter to Ligand’s Captisol® customers. The full text of that letter is as follows: To Our Valued Captisol Customers, Ligand is in a period of momentous planning and scale-up. As you may know, Captisol is a key ingredient […]

Press Releases May 27, 2020

FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCKTM (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

May 15, 2020 QINLOCK Significantly Improved Progression-Free Survival and Showed Clinically Meaningful Overall Survival in INVICTUS Phase 3 Study NDA Approved 3 Months Prior to Action Date Under FDA’s Real Time Oncology Review (RTOR) Deciphera to Host Conference Call Today at 5:00 PM Eastern Time   WALTHAM, Mass.–(BUSINESS WIRE)–May 15, 2020– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) […]

Press Releases May 05, 2020

ADARE PHARMACEUTICALS, INC. ACQUIRES ORBIS BIOSCIENCES

Lawrenceville, NJ, and Lenexa, KS – May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual property Deal includes platforms that can be dosed in oral, injectable and otic (ear) formulations Acquisition expands Adare’s technology platforms and product development capabilities Adare Pharmaceuticals, Inc., a clinical-stage pharmaceutical company and leading global provider of advanced […]